Clinical Trials in New York

Showing 3821-3840 of 22,668 trials

Liver Transplantation for Unresectable Liver Limited Colorectal Metastases

NCT04742621

This is a single-arm, single institution pilot registry of liver transplantation in patients with unresectable colorectal liver-only metastases at Weill Cornell Medical College. Patients with liver predominant colorectal liver metastases will be screened based on eligibility criteria in a specified clinical hepatobiliary and colorectal liver metastasis tumor board consisting of the principal and co-investigators, representing medical oncology, transplant surgery, radiology, and pathology. The registry aims to track basic demographic data as well as referral patterns, in addition to specific oncologic data such as tumor burden, extent of disease, extent of disease on explant, recurrence rates, patterns of recurrence and survival rates.

Unresectable Liver-limited Colorectal Metastases

Weill Medical College of Cornell University20 participantsStarted Sep 2020

New York, New York, United States

TERMINATEDPhase 2< 1 mile

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

NCT04686786

The purpose of this study is to assess the long-term safety and tolerability of CVL-865 as adjunctive therapy in participants with focal onset seizures.

Seizures

AbbVie105 participantsStarted Dec 2020

Little Rock, Arkansas, United States • New Haven, Connecticut, United States • Gulf Breeze, Florida, United States +53 more locations

Liver Transplantation for Unresectable Liver Limited Colorectal Metastases

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Find Trials by Condition in New York

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Adjunctive Cannabidiol for Recovery From Opioid Study

ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM)

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

Abatacept as GVHD Prophylaxis Phase 2

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

Evaluation of A Clinical Diagnostic Test for CRDS

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant